On the in vivo significance of bacterial resistance to antimicrobial peptides

Margaret Bauer, William M. Shafer

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Antimicrobial peptides (AMPs) are at the front-line of host defense during infection and play critical roles both in reducing the microbial load early during infection and in linking innate to adaptive immunity. However, successful pathogens have developed mechanisms to resist AMPs. Although considerable progress has been made in elucidating AMP-resistance mechanisms of pathogenic bacteria in vitro, less is known regarding the in vivo significance of such resistance. Nevertheless, progress has been made in this area, largely by using murine models and, in two instances, human models of infection. Herein, we review progress on the use of in vivo infection models in AMP research and discuss the AMP resistance mechanisms that have been established by in vivo studies to contribute to microbial infection. We posit that in vivo infection models are essential tools for investigators to understand the significance to pathogenesis of genetic changes that impact levels of bacterial susceptibility to AMPs. This article is part of a Special Issue entitled: Bacterial Resistance to Antimicrobial Peptides.

Original languageEnglish (US)
Article number81818
Pages (from-to)3101-3111
Number of pages11
JournalBiochimica et Biophysica Acta - Biomembranes
Volume1848
Issue number11
DOIs
StatePublished - Feb 7 2015

Fingerprint

Peptides
Infection
Adaptive Immunity
Pathogens
Bacteria
Research Personnel
Research

Keywords

  • Antimicrobial peptides
  • Cell envelope modifications
  • In vivo models
  • Pathogenesis
  • Resistance mechanisms
  • Transporters

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Biophysics

Cite this

On the in vivo significance of bacterial resistance to antimicrobial peptides. / Bauer, Margaret; Shafer, William M.

In: Biochimica et Biophysica Acta - Biomembranes, Vol. 1848, No. 11, 81818, 07.02.2015, p. 3101-3111.

Research output: Contribution to journalArticle

@article{b68217291a154beaa012117df2f0b4f2,
title = "On the in vivo significance of bacterial resistance to antimicrobial peptides",
abstract = "Antimicrobial peptides (AMPs) are at the front-line of host defense during infection and play critical roles both in reducing the microbial load early during infection and in linking innate to adaptive immunity. However, successful pathogens have developed mechanisms to resist AMPs. Although considerable progress has been made in elucidating AMP-resistance mechanisms of pathogenic bacteria in vitro, less is known regarding the in vivo significance of such resistance. Nevertheless, progress has been made in this area, largely by using murine models and, in two instances, human models of infection. Herein, we review progress on the use of in vivo infection models in AMP research and discuss the AMP resistance mechanisms that have been established by in vivo studies to contribute to microbial infection. We posit that in vivo infection models are essential tools for investigators to understand the significance to pathogenesis of genetic changes that impact levels of bacterial susceptibility to AMPs. This article is part of a Special Issue entitled: Bacterial Resistance to Antimicrobial Peptides.",
keywords = "Antimicrobial peptides, Cell envelope modifications, In vivo models, Pathogenesis, Resistance mechanisms, Transporters",
author = "Margaret Bauer and Shafer, {William M.}",
year = "2015",
month = "2",
day = "7",
doi = "10.1016/j.bbamem.2015.02.012",
language = "English (US)",
volume = "1848",
pages = "3101--3111",
journal = "Biochimica et Biophysica Acta - Biomembranes",
issn = "0005-2736",
publisher = "Elsevier",
number = "11",

}

TY - JOUR

T1 - On the in vivo significance of bacterial resistance to antimicrobial peptides

AU - Bauer, Margaret

AU - Shafer, William M.

PY - 2015/2/7

Y1 - 2015/2/7

N2 - Antimicrobial peptides (AMPs) are at the front-line of host defense during infection and play critical roles both in reducing the microbial load early during infection and in linking innate to adaptive immunity. However, successful pathogens have developed mechanisms to resist AMPs. Although considerable progress has been made in elucidating AMP-resistance mechanisms of pathogenic bacteria in vitro, less is known regarding the in vivo significance of such resistance. Nevertheless, progress has been made in this area, largely by using murine models and, in two instances, human models of infection. Herein, we review progress on the use of in vivo infection models in AMP research and discuss the AMP resistance mechanisms that have been established by in vivo studies to contribute to microbial infection. We posit that in vivo infection models are essential tools for investigators to understand the significance to pathogenesis of genetic changes that impact levels of bacterial susceptibility to AMPs. This article is part of a Special Issue entitled: Bacterial Resistance to Antimicrobial Peptides.

AB - Antimicrobial peptides (AMPs) are at the front-line of host defense during infection and play critical roles both in reducing the microbial load early during infection and in linking innate to adaptive immunity. However, successful pathogens have developed mechanisms to resist AMPs. Although considerable progress has been made in elucidating AMP-resistance mechanisms of pathogenic bacteria in vitro, less is known regarding the in vivo significance of such resistance. Nevertheless, progress has been made in this area, largely by using murine models and, in two instances, human models of infection. Herein, we review progress on the use of in vivo infection models in AMP research and discuss the AMP resistance mechanisms that have been established by in vivo studies to contribute to microbial infection. We posit that in vivo infection models are essential tools for investigators to understand the significance to pathogenesis of genetic changes that impact levels of bacterial susceptibility to AMPs. This article is part of a Special Issue entitled: Bacterial Resistance to Antimicrobial Peptides.

KW - Antimicrobial peptides

KW - Cell envelope modifications

KW - In vivo models

KW - Pathogenesis

KW - Resistance mechanisms

KW - Transporters

UR - http://www.scopus.com/inward/record.url?scp=84943665377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943665377&partnerID=8YFLogxK

U2 - 10.1016/j.bbamem.2015.02.012

DO - 10.1016/j.bbamem.2015.02.012

M3 - Article

C2 - 25701234

AN - SCOPUS:84943665377

VL - 1848

SP - 3101

EP - 3111

JO - Biochimica et Biophysica Acta - Biomembranes

JF - Biochimica et Biophysica Acta - Biomembranes

SN - 0005-2736

IS - 11

M1 - 81818

ER -